<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="185548">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678379</url>
  </required_header>
  <id_info>
    <org_study_id>080127</org_study_id>
    <nct_id>NCT00678379</nct_id>
  </id_info>
  <brief_title>Pediatric Tonsillectomy Pain Reduction Study</brief_title>
  <official_title>Pediatric Tonsillectomy Pain Reduction Study, a Randomized, Placebo Controlled, Double-Blind Clinical Trial Using Clonidine and Local Anesthetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tonsillectomy is associated with a significant decrease quality of life in children
      secondary to pain, which is worsened with swallowing. Previous studies in the pediatric
      population have demonstrated a significant decrease in post-operative pain/morbidity when
      administering pain reduction medications into the tonsillar fossa prior to removal. While
      these studies have shown great promise, no large randomized trial of the most promising
      medications has been conducted. Because of this, many otolaryngologists do not administer
      intra-operative medications aimed at reducing post-operative pain. The objective of the
      current study is to conduct a prospective, double-blind, placebo-controlled, randomized
      clinical trial using a pre-tonsillectomy infiltration of the tonsillar fossa comparing three
      treatment regimens in reducing post-tonsillectomy morbidity (i.e. pain, poor oral intake):
      1) Placebo (saline injection) 2) bupivacaine (0.5%) + lidocaine (1%), 3) bupivacaine (0.5%)
      + lidocaine (1%) + clonidine (25 Âµg).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total number of post-operative doses of analgesics.</measure>
    <time_frame>Post-operative days 1,3,5 &amp; 7</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean number of pain medication doses per day.</measure>
    <time_frame>in recovery room; post-operative days 1,3,5 &amp; 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total time until discharge from hospital.</measure>
    <time_frame>Day of Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean visual analog scale pain number.</measure>
    <time_frame>in recovery room; post-operative days 1,3,5 &amp; 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of diet patient is able to tolerate.</measure>
    <time_frame>post-opeartive days 1,3,5 &amp; 7.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal Saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine (1%) + Bupivacaine 0.5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine 1% + Bupivacaine o.5% + Clondine 25mcg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine + bupivacaine</intervention_name>
    <description>Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
B - lidocaine (1%) + bupivacaine (0.5%)</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Duraclon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
A - normal saline</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine + bupivacaine + clonidine</intervention_name>
    <description>Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy with one of three injections.
C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 3 - 17 years old

          -  BMI &lt; 35

          -  Negative pregnancy test in female patients age 10 and older

          -  Diagnosed with adenotonsillar hypertrophy, recurrent adenotonsillitis or upper airway
             obstruction and will be undergoing tonsillectomy alone or adenotonsillectomy

        Exclusion Criteria:

          -  Diagnosis of obstructive sleep apnea

          -  Patient with peritonsillar abscess

          -  Allergy to study medication

          -  Any major systemic illness, genetic disorder or diagnosed syndrome

          -  Bleeding disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan R Moss, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Monroe Carrel Jr. Children's Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37299</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cucchiaro G, Ganesh A. The effects of clonidine on postoperative analgesia after peripheral nerve blockade in children. Anesth Analg. 2007 Mar;104(3):532-7.</citation>
    <PMID>17312203</PMID>
  </reference>
  <reference>
    <citation>Naja MZ, El-Rajab M, Kabalan W, Ziade MF, Al-Tannir MA. Pre-incisional infiltration for pediatric tonsillectomy: a randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2005 Oct;69(10):1333-41. Epub 2005 Apr 22.</citation>
    <PMID>16159655</PMID>
  </reference>
  <reference>
    <citation>McCartney CJ, Duggan E, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007 Jul-Aug;32(4):330-8. Review.</citation>
    <PMID>17720118</PMID>
  </reference>
  <reference>
    <citation>Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL Jr, Kissin I. Tonsillectomy and adenoidectomy pain reduction by local bupivacaine infiltration in children. Int J Pediatr Otorhinolaryngol. 1993 Jan;25(1-3):149-54.</citation>
    <PMID>8436459</PMID>
  </reference>
  <reference>
    <citation>Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL Jr, Kissin I. The effect of pre-incisional infiltration of tonsils with bupivacaine on the pain following tonsillectomy under general anesthesia. Pain. 1991 Dec;47(3):305-8.</citation>
    <PMID>1784501</PMID>
  </reference>
  <reference>
    <citation>Giannoni C, White S, Enneking FK, Morey T. Ropivacaine with or without clonidine improves pediatric tonsillectomy pain. Arch Otolaryngol Head Neck Surg. 2001 Oct;127(10):1265-70.</citation>
    <PMID>11587610</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <lastchanged_date>December 10, 2009</lastchanged_date>
  <firstreceived_date>May 8, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Jonathan R. Moss, MD MPH</name_title>
    <organization>Vanderbilt University Medical Center</organization>
  </responsible_party>
  <keyword>Tonsillectomy</keyword>
  <keyword>Postoperative Pain</keyword>
  <keyword>Clonidine</keyword>
  <keyword>Anesthetics, Local</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
